These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20710138)

  • 41. Nonalcoholic fatty liver disease of obesity.
    Sachdev MS; Riely CA; Madan AK
    Obes Surg; 2006 Nov; 16(11):1412-9. PubMed ID: 17132404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of nonalcoholic fatty liver: present and emerging therapies.
    Angulo P; Lindor KD
    Semin Liver Dis; 2001; 21(1):81-8. PubMed ID: 11296699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Obesity and liver disease.
    Scheen AJ; Luyckx FH
    Best Pract Res Clin Endocrinol Metab; 2002 Dec; 16(4):703-16. PubMed ID: 12468416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treating nonalcoholic fatty liver disease.
    Méndez-Sánchez N; Arrese M; Zamora-Valdés D; Uribe M
    Liver Int; 2007 Nov; 27(9):1157-65. PubMed ID: 17919226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].
    Hagymási K; Reismann P; Rácz K; Tulassay Z
    Orv Hetil; 2009 Nov; 150(48):2173-81. PubMed ID: 19923096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of non-alcoholic steatohepatitis.
    Angulo P; Lindor KD
    Best Pract Res Clin Gastroenterol; 2002 Oct; 16(5):797-810. PubMed ID: 12406446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.
    Barshop NJ; Sirlin CB; Schwimmer JB; Lavine JE
    Aliment Pharmacol Ther; 2008 Jul; 28(1):13-24. PubMed ID: 18397387
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Non-alcoholic steatohepatitis].
    Alvarez-Martínez H; Pérez-Campos E
    Rev Gastroenterol Mex; 2002; 67(2):118-25. PubMed ID: 12214335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of non-alcoholic fatty liver disease].
    Koek GH
    Ned Tijdschr Geneeskd; 2011; 155():A3181. PubMed ID: 21649947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The spectrum of nonalcoholic fatty liver disease: from steatosis to nonalcoholic steatohepatitis.
    Saadeh S; Younossi ZM
    Cleve Clin J Med; 2000 Feb; 67(2):96-7, 101-4. PubMed ID: 10680276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of nonalcoholic fatty liver disease.
    Angulo P
    Ann Hepatol; 2002; 1(1):12-9. PubMed ID: 15114291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 1. Nonalcoholic fatty liver disease].
    Takamura T
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):836-44. PubMed ID: 23772495
    [No Abstract]   [Full Text] [Related]  

  • 53. Nonalcoholic fatty liver disease is associated with hyperlipidemia and obesity.
    Sharabi Y; Eldad A
    Am J Med; 2000 Aug; 109(2):171. PubMed ID: 11032566
    [No Abstract]   [Full Text] [Related]  

  • 54. [Non-alcoholic fatty liver disease].
    Wójcik K; Piekarska A
    Pol Arch Med Wewn; 2006 Feb; 115(2):172-81. PubMed ID: 17274475
    [No Abstract]   [Full Text] [Related]  

  • 55. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance.
    James OF; Day CP
    J Hepatol; 1998 Sep; 29(3):495-501. PubMed ID: 9765002
    [No Abstract]   [Full Text] [Related]  

  • 56. Nonalcoholic fatty liver disease.
    Angulo P
    N Engl J Med; 2002 Apr; 346(16):1221-31. PubMed ID: 11961152
    [No Abstract]   [Full Text] [Related]  

  • 57. [Are there therapeutic approaches of non-alcoholic fatty liver disease and its complications?].
    Strahl S; Maier KP
    Internist (Berl); 2008 Dec; 49(12):1421-2, 1424-7. PubMed ID: 19002423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonalcoholic fatty liver disease.
    Fitzgerald MA
    Nurse Pract; 2007 Feb; 32(2):24-5. PubMed ID: 17264787
    [No Abstract]   [Full Text] [Related]  

  • 59. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?
    Day CP
    Gut; 2002 May; 50(5):585-8. PubMed ID: 11950797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonalcoholic fatty liver disease in the pediatric population: a review.
    Wieckowska A; Feldstein AE
    Curr Opin Pediatr; 2005 Oct; 17(5):636-41. PubMed ID: 16160540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.